APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxychloroquine (Plaquenil)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hydroxychloroquine (Plaquenil) Market Analysis and Forecast 2026-2032

31 December 2025216 pages

Choose your research edition.

Industry ResearchHydroxychloroquine (Plaquenil) Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxychloroquine (Plaquenil) Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Hydroxychloroquine (Plaquenil) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxychloroquine (Plaquenil) Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxychloroquine (Plaquenil) Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Hydroxychloroquine (Plaquenil) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hydroxychloroquine (Plaquenil) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hydroxychloroquine (Plaquenil) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hydroxychloroquine (Plaquenil) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hydroxychloroquine (Plaquenil) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hydroxychloroquine (Plaquenil) include Actavis (TEVA ), Advanz Pharma, Aphena Pharma, Apotex Corporation, AvKARE (Amneal Pharmaceuticals), Bristol Laboratories, Cadila Healthcare, Cardinal Health and Cinkate Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hydroxychloroquine (Plaquenil), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hydroxychloroquine (Plaquenil), also provides the sales of main regions and countries. Of the upcoming market potential for Hydroxychloroquine (Plaquenil), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hydroxychloroquine (Plaquenil) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hydroxychloroquine (Plaquenil) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hydroxychloroquine (Plaquenil) sales, projected growth trends, production technology, application and end-user industry.

Hydroxychloroquine (Plaquenil) Segment by Company

Actavis (TEVA )

Advanz Pharma

Aphena Pharma

Apotex Corporation

AvKARE (Amneal Pharmaceuticals)

Bristol Laboratories

Cadila Healthcare

Cardinal Health

Cinkate Corporation

Concordia Healthcare

Covis Pharmaceutical

Hanlim Pharmaceutical

Hikma Pharmaceuticals

Ipca Laboratories

Kyung Poong

Taj Pharmaceuticals

Zydus Cadila

Mylan

Novartis

Sanofi

Shanghai Pharmaceuticals Holding

Sun Pharma

Hydroxychloroquine (Plaquenil) Segment by Type

100mg

200mg

Other

Hydroxychloroquine (Plaquenil) Segment by Application

COVID-19

Rheumatoid Arthritis

Lupus Erythematosus

Others

Hydroxychloroquine (Plaquenil) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine (Plaquenil) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine (Plaquenil) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine (Plaquenil).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hydroxychloroquine (Plaquenil) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hydroxychloroquine (Plaquenil) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hydroxychloroquine (Plaquenil) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hydroxychloroquine (Plaquenil) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100mg Major Manufacturers Table 3. 200mg Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Hydroxychloroquine (Plaquenil) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. COVID-19 Major Manufacturers Table 7. Rheumatoid Arthritis Major Manufacturers Table 8. Lupus Erythematosus Major Manufacturers Table 9. Others Major Manufacturers Table 10. Hydroxychloroquine (Plaquenil) Industry Trends Table 11. Hydroxychloroquine (Plaquenil) Industry Drivers Table 12. Hydroxychloroquine (Plaquenil) Industry Opportunities and Challenges Table 13. Hydroxychloroquine (Plaquenil) Industry Restraints Table 14. Global Hydroxychloroquine (Plaquenil) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Hydroxychloroquine (Plaquenil) Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Hydroxychloroquine (Plaquenil) Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region (2021-2026) Table 18. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region (2027-2032) Table 19. Global Hydroxychloroquine (Plaquenil) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 20. Global Hydroxychloroquine (Plaquenil) Sales by Region (2021-2026) & (M Pcs) Table 21. Global Hydroxychloroquine (Plaquenil) Sales by Region (2027-2032) & (M Pcs) Table 22. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Region (2021-2026) Table 23. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Region (2027-2032) Table 24. Global Hydroxychloroquine (Plaquenil) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Hydroxychloroquine (Plaquenil) Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Manufacturers (2021-2026) Table 28. Global Hydroxychloroquine (Plaquenil) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Hydroxychloroquine (Plaquenil) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Hydroxychloroquine (Plaquenil) Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Hydroxychloroquine (Plaquenil) Manufacturers, Product Type & Application Table 32. Global Hydroxychloroquine (Plaquenil) Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Hydroxychloroquine (Plaquenil) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Hydroxychloroquine (Plaquenil) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Hydroxychloroquine (Plaquenil) Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type (2021-2026) Table 39. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type (2027-2032) Table 40. Global Hydroxychloroquine (Plaquenil) Sales by Type 2021 VS 2025 VS 2032 (M Pcs) Table 41. Global Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 42. Global Hydroxychloroquine (Plaquenil) Sales by Type (2027-2032) & (M Pcs) Table 43. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2021-2026) Table 44. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2027-2032) Table 45. Global Hydroxychloroquine (Plaquenil) Price by Type (2021-2026) & (US$/Unit) Table 46. Global Hydroxychloroquine (Plaquenil) Price by Type (2027-2032) & (US$/Unit) Table 47. Global Hydroxychloroquine (Plaquenil) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Hydroxychloroquine (Plaquenil) Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application (2021-2026) Table 51. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application (2027-2032) Table 52. Global Hydroxychloroquine (Plaquenil) Sales by Application 2021 VS 2025 VS 2032 (M Pcs) Table 53. Global Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 54. Global Hydroxychloroquine (Plaquenil) Sales by Application (2027-2032) & (M Pcs) Table 55. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2021-2026) Table 56. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2027-2032) Table 57. Global Hydroxychloroquine (Plaquenil) Price by Application (2021-2026) & (US$/Unit) Table 58. Global Hydroxychloroquine (Plaquenil) Price by Application (2027-2032) & (US$/Unit) Table 59. Actavis (TEVA ) Company Information Table 60. Actavis (TEVA ) Business Overview Table 61. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product Portfolio Table 63. Actavis (TEVA ) Recent Development Table 64. Advanz Pharma Company Information Table 65. Advanz Pharma Business Overview Table 66. Advanz Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Advanz Pharma Hydroxychloroquine (Plaquenil) Product Portfolio Table 68. Advanz Pharma Recent Development Table 69. Aphena Pharma Company Information Table 70. Aphena Pharma Business Overview Table 71. Aphena Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Aphena Pharma Hydroxychloroquine (Plaquenil) Product Portfolio Table 73. Aphena Pharma Recent Development Table 74. Apotex Corporation Company Information Table 75. Apotex Corporation Business Overview Table 76. Apotex Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Apotex Corporation Hydroxychloroquine (Plaquenil) Product Portfolio Table 78. Apotex Corporation Recent Development Table 79. AvKARE (Amneal Pharmaceuticals) Company Information Table 80. AvKARE (Amneal Pharmaceuticals) Business Overview Table 81. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product Portfolio Table 83. AvKARE (Amneal Pharmaceuticals) Recent Development Table 84. Bristol Laboratories Company Information Table 85. Bristol Laboratories Business Overview Table 86. Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Bristol Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio Table 88. Bristol Laboratories Recent Development Table 89. Cadila Healthcare Company Information Table 90. Cadila Healthcare Business Overview Table 91. Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Cadila Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio Table 93. Cadila Healthcare Recent Development Table 94. Cardinal Health Company Information Table 95. Cardinal Health Business Overview Table 96. Cardinal Health Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Cardinal Health Hydroxychloroquine (Plaquenil) Product Portfolio Table 98. Cardinal Health Recent Development Table 99. Cinkate Corporation Company Information Table 100. Cinkate Corporation Business Overview Table 101. Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Cinkate Corporation Hydroxychloroquine (Plaquenil) Product Portfolio Table 103. Cinkate Corporation Recent Development Table 104. Concordia Healthcare Company Information Table 105. Concordia Healthcare Business Overview Table 106. Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Concordia Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio Table 108. Concordia Healthcare Recent Development Table 109. Covis Pharmaceutical Company Information Table 110. Covis Pharmaceutical Business Overview Table 111. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio Table 113. Covis Pharmaceutical Recent Development Table 114. Hanlim Pharmaceutical Company Information Table 115. Hanlim Pharmaceutical Business Overview Table 116. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio Table 118. Hanlim Pharmaceutical Recent Development Table 119. Hikma Pharmaceuticals Company Information Table 120. Hikma Pharmaceuticals Business Overview Table 121. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio Table 123. Hikma Pharmaceuticals Recent Development Table 124. Ipca Laboratories Company Information Table 125. Ipca Laboratories Business Overview Table 126. Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Ipca Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio Table 128. Ipca Laboratories Recent Development Table 129. Kyung Poong Company Information Table 130. Kyung Poong Business Overview Table 131. Kyung Poong Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Kyung Poong Hydroxychloroquine (Plaquenil) Product Portfolio Table 133. Kyung Poong Recent Development Table 134. Taj Pharmaceuticals Company Information Table 135. Taj Pharmaceuticals Business Overview Table 136. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio Table 138. Taj Pharmaceuticals Recent Development Table 139. Zydus Cadila Company Information Table 140. Zydus Cadila Business Overview Table 141. Zydus Cadila Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Zydus Cadila Hydroxychloroquine (Plaquenil) Product Portfolio Table 143. Zydus Cadila Recent Development Table 144. Mylan Company Information Table 145. Mylan Business Overview Table 146. Mylan Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Mylan Hydroxychloroquine (Plaquenil) Product Portfolio Table 148. Mylan Recent Development Table 149. Novartis Company Information Table 150. Novartis Business Overview Table 151. Novartis Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Novartis Hydroxychloroquine (Plaquenil) Product Portfolio Table 153. Novartis Recent Development Table 154. Sanofi Company Information Table 155. Sanofi Business Overview Table 156. Sanofi Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Sanofi Hydroxychloroquine (Plaquenil) Product Portfolio Table 158. Sanofi Recent Development Table 159. Shanghai Pharmaceuticals Holding Company Information Table 160. Shanghai Pharmaceuticals Holding Business Overview Table 161. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product Portfolio Table 163. Shanghai Pharmaceuticals Holding Recent Development Table 164. Sun Pharma Company Information Table 165. Sun Pharma Business Overview Table 166. Sun Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Sun Pharma Hydroxychloroquine (Plaquenil) Product Portfolio Table 168. Sun Pharma Recent Development Table 169. North America Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2026) & (US$ Million) Table 170. North America Hydroxychloroquine (Plaquenil) Revenue by Type (2027-2032) & (US$ Million) Table 171. North America Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 172. North America Hydroxychloroquine (Plaquenil) Sales by Type (2027-2032) & (M Pcs) Table 173. North America Hydroxychloroquine (Plaquenil) Sales Price by Type (2021-2026) & (US$/Unit) Table 174. North America Hydroxychloroquine (Plaquenil) Sales Price by Type (2027-2032) & (US$/Unit) Table 175. North America Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2026) & (US$ Million) Table 176. North America Hydroxychloroquine (Plaquenil) Revenue by Application (2027-2032) & (US$ Million) Table 177. North America Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 178. North America Hydroxychloroquine (Plaquenil) Sales by Application (2027-2032) & (M Pcs) Table 179. North America Hydroxychloroquine (Plaquenil) Sales Price by Application (2021-2026) & (US$/Unit) Table 180. North America Hydroxychloroquine (Plaquenil) Sales Price by Application (2027-2032) & (US$/Unit) Table 181. North America Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. North America Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 183. North America Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 184. North America Hydroxychloroquine (Plaquenil) Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 185. North America Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 186. North America Hydroxychloroquine (Plaquenil) Sales by Country (2027-2032) & (M Pcs) Table 187. North America Hydroxychloroquine (Plaquenil) Sales Price by Country (2021-2026) & (US$/Unit) Table 188. North America Hydroxychloroquine (Plaquenil) Sales Price by Country (2027-2032) & (US$/Unit) Table 189. United States Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 190. Canada Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 191. Europe Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2026) & (US$ Million) Table 192. Europe Hydroxychloroquine (Plaquenil) Revenue by Type (2027-2032) & (US$ Million) Table 193. Europe Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 194. Europe Hydroxychloroquine (Plaquenil) Sales by Type (2027-2032) & (M Pcs) Table 195. Europe Hydroxychloroquine (Plaquenil) Sales Price by Type (2021-2026) & (US$/Unit) Table 196. Europe Hydroxychloroquine (Plaquenil) Sales Price by Type (2027-2032) & (US$/Unit) Table 197. Europe Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2026) & (US$ Million) Table 198. Europe Hydroxychloroquine (Plaquenil) Revenue by Application (2027-2032) & (US$ Million) Table 199. Europe Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 200. Europe Hydroxychloroquine (Plaquenil) Sales by Application (2027-2032) & (M Pcs) Table 201. Europe Hydroxychloroquine (Plaquenil) Sales Price by Application (2021-2026) & (US$/Unit) Table 202. Europe Hydroxychloroquine (Plaquenil) Sales Price by Application (2027-2032) & (US$/Unit) Table 203. Europe Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. Europe Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. Europe Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. Europe Hydroxychloroquine (Plaquenil) Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 207. Europe Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 208. Europe Hydroxychloroquine (Plaquenil) Sales by Country (2027-2032) & (M Pcs) Table 209. Europe Hydroxychloroquine (Plaquenil) Sales Price by Country (2021-2026) & (US$/Unit) Table 210. Europe Hydroxychloroquine (Plaquenil) Sales Price by Country (2027-2032) & (US$/Unit) Table 211. Germany Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 212. France Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 213. U.K. Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 214. Italy Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 215. Netherlands Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 216. China Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2026) & (US$ Million) Table 217. China Hydroxychloroquine (Plaquenil) Revenue by Type (2027-2032) & (US$ Million) Table 218. China Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 219. China Hydroxychloroquine (Plaquenil) Sales by Type (2027-2032) & (M Pcs) Table 220. China Hydroxychloroquine (Plaquenil) Sales Price by Type (2021-2026) & (US$/Unit) Table 221. China Hydroxychloroquine (Plaquenil) Sales Price by Type (2027-2032) & (US$/Unit) Table 222. China Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2026) & (US$ Million) Table 223. China Hydroxychloroquine (Plaquenil) Revenue by Application (2027-2032) & (US$ Million) Table 224. China Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 225. China Hydroxychloroquine (Plaquenil) Sales by Application (2027-2032) & (M Pcs) Table 226. China Hydroxychloroquine (Plaquenil) Sales Price by Application (2021-2026) & (US$/Unit) Table 227. China Hydroxychloroquine (Plaquenil) Sales Price by Application (2027-2032) & (US$/Unit) Table 228. Asia Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2026) & (US$ Million) Table 229. Asia Hydroxychloroquine (Plaquenil) Revenue by Type (2027-2032) & (US$ Million) Table 230. Asia Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 231. Asia Hydroxychloroquine (Plaquenil) Sales by Type (2027-2032) & (M Pcs) Table 232. Asia Hydroxychloroquine (Plaquenil) Sales Price by Type (2021-2026) & (US$/Unit) Table 233. Asia Hydroxychloroquine (Plaquenil) Sales Price by Type (2027-2032) & (US$/Unit) Table 234. Asia Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2026) & (US$ Million) Table 235. Asia Hydroxychloroquine (Plaquenil) Revenue by Application (2027-2032) & (US$ Million) Table 236. Asia Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 237. Asia Hydroxychloroquine (Plaquenil) Sales by Application (2027-2032) & (M Pcs) Table 238. Asia Hydroxychloroquine (Plaquenil) Sales Price by Application (2021-2026) & (US$/Unit) Table 239. Asia Hydroxychloroquine (Plaquenil) Sales Price by Application (2027-2032) & (US$/Unit) Table 240. Asia Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. Asia Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. Asia Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. Asia Hydroxychloroquine (Plaquenil) Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 244. Asia Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 245. Asia Hydroxychloroquine (Plaquenil) Sales by Country (2027-2032) & (M Pcs) Table 246. Asia Hydroxychloroquine (Plaquenil) Sales Price by Country (2021-2026) & (US$/Unit) Table 247. Asia Hydroxychloroquine (Plaquenil) Sales Price by Country (2027-2032) & (US$/Unit) Table 248. Japan Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 249. South Korea Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 250. India Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 251. Australia Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 252. China Taiwan Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 253. Southeast Asia Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 254. SAMEA Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2026) & (US$ Million) Table 255. SAMEA Hydroxychloroquine (Plaquenil) Revenue by Type (2027-2032) & (US$ Million) Table 256. SAMEA Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 257. SAMEA Hydroxychloroquine (Plaquenil) Sales by Type (2027-2032) & (M Pcs) Table 258. SAMEA Hydroxychloroquine (Plaquenil) Sales Price by Type (2021-2026) & (US$/Unit) Table 259. SAMEA Hydroxychloroquine (Plaquenil) Sales Price by Type (2027-2032) & (US$/Unit) Table 260. SAMEA Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2026) & (US$ Million) Table 261. SAMEA Hydroxychloroquine (Plaquenil) Revenue by Application (2027-2032) & (US$ Million) Table 262. SAMEA Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 263. SAMEA Hydroxychloroquine (Plaquenil) Sales by Application (2027-2032) & (M Pcs) Table 264. SAMEA Hydroxychloroquine (Plaquenil) Sales Price by Application (2021-2026) & (US$/Unit) Table 265. SAMEA Hydroxychloroquine (Plaquenil) Sales Price by Application (2027-2032) & (US$/Unit) Table 266. SAMEA Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 267. SAMEA Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 268. SAMEA Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 269. SAMEA Hydroxychloroquine (Plaquenil) Sales by Country (2021 VS 2025 VS 2032) & (M Pcs) Table 270. SAMEA Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 271. SAMEA Hydroxychloroquine (Plaquenil) Sales by Country (2027-2032) & (M Pcs) Table 272. SAMEA Hydroxychloroquine (Plaquenil) Sales Price by Country (2021-2026) & (US$/Unit) Table 273. SAMEA Hydroxychloroquine (Plaquenil) Sales Price by Country (2027-2032) & (US$/Unit) Table 274. Brazil Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 275. Argentina Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 276. Chile Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 277. Colombia Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 278. Peru Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 279. Saudi Arabia Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 280. Israel Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 281. UAE Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 282. Turkey Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 283. Iran Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 284. Egypt Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Table 285. Key Raw Materials Table 286. Raw Materials Key Suppliers Table 287. Hydroxychloroquine (Plaquenil) Distributors List Table 288. Hydroxychloroquine (Plaquenil) Customers List Table 289. Research Programs/Design for This Report Table 290. Authors List of This Report Table 291. Secondary Sources Table 292. Primary Sources List of Figures Figure 1. Hydroxychloroquine (Plaquenil) Image Figure 2. Global Hydroxychloroquine (Plaquenil) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxychloroquine (Plaquenil) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100mg Image Figure 5. 200mg Image Figure 6. Other Image Figure 7. Global Hydroxychloroquine (Plaquenil) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Hydroxychloroquine (Plaquenil) Market Size Share 2021 VS 2025 VS 2032 Figure 9. COVID-19 Image Figure 10. Rheumatoid Arthritis Image Figure 11. Lupus Erythematosus Image Figure 12. Others Image Figure 13. Global Hydroxychloroquine (Plaquenil) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Figure 15. Global Hydroxychloroquine (Plaquenil) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region (2021-2032) Figure 18. Global Hydroxychloroquine (Plaquenil) Sales (2021-2032) & (M Pcs) Figure 19. Global Hydroxychloroquine (Plaquenil) Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Figure 20. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Hydroxychloroquine (Plaquenil) Sales YoY (2021-2032) & (M Pcs) Figure 22. Europe Hydroxychloroquine (Plaquenil) Sales YoY (2021-2032) & (M Pcs) Figure 23. China Hydroxychloroquine (Plaquenil) Sales YoY (2021-2032) & (M Pcs) Figure 24. Asia (Excluding China) Hydroxychloroquine (Plaquenil) Sales YoY (2021-2032) & (M Pcs) Figure 25. South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Sales YoY (2021-2032) & (M Pcs) Figure 26. Global Hydroxychloroquine (Plaquenil) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Hydroxychloroquine (Plaquenil) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Hydroxychloroquine (Plaquenil) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type (2021-2032) Figure 32. Global Hydroxychloroquine (Plaquenil) Sales by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 33. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2021-2032) Figure 35. Global Hydroxychloroquine (Plaquenil) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application (2021-2032) Figure 38. Global Hydroxychloroquine (Plaquenil) Sales by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 39. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2021-2032) Figure 41. North America Hydroxychloroquine (Plaquenil) Revenue Share by Type (2021-2032) Figure 42. North America Hydroxychloroquine (Plaquenil) Sales Share by Type (2021-2032) Figure 43. North America Hydroxychloroquine (Plaquenil) Revenue Share by Application (2021-2032) Figure 44. North America Hydroxychloroquine (Plaquenil) Sales Share by Application (2021-2032) Figure 45. North America Hydroxychloroquine (Plaquenil) Revenue Share by Country (2021-2032) Figure 46. North America Hydroxychloroquine (Plaquenil) Sales Share by Country (2021-2032) Figure 47. Europe Hydroxychloroquine (Plaquenil) Revenue Share by Type (2021-2032) Figure 48. Europe Hydroxychloroquine (Plaquenil) Sales Share by Type (2021-2032) Figure 49. Europe Hydroxychloroquine (Plaquenil) Revenue Share by Application (2021-2032) Figure 50. Europe Hydroxychloroquine (Plaquenil) Sales Share by Application (2021-2032) Figure 51. Europe Hydroxychloroquine (Plaquenil) Revenue Share by Country (2021-2032) Figure 52. Europe Hydroxychloroquine (Plaquenil) Sales Share by Country (2021-2032) Figure 53. China Hydroxychloroquine (Plaquenil) Revenue Share by Type (2021-2032) Figure 54. China Hydroxychloroquine (Plaquenil) Sales Share by Type (2021-2032) Figure 55. China Hydroxychloroquine (Plaquenil) Revenue Share by Application (2021-2032) Figure 56. China Hydroxychloroquine (Plaquenil) Sales Share by Application (2021-2032) Figure 57. Asia Hydroxychloroquine (Plaquenil) Revenue Share by Type (2021-2032) Figure 58. Asia Hydroxychloroquine (Plaquenil) Sales Share by Type (2021-2032) Figure 59. Asia Hydroxychloroquine (Plaquenil) Revenue Share by Application (2021-2032) Figure 60. Asia Hydroxychloroquine (Plaquenil) Sales Share by Application (2021-2032) Figure 61. Asia Hydroxychloroquine (Plaquenil) Revenue Share by Country (2021-2032) Figure 62. Asia Hydroxychloroquine (Plaquenil) Sales Share by Country (2021-2032) Figure 63. SAMEA Hydroxychloroquine (Plaquenil) Revenue Share by Type (2021-2032) Figure 64. SAMEA Hydroxychloroquine (Plaquenil) Sales Share by Type (2021-2032) Figure 65. SAMEA Hydroxychloroquine (Plaquenil) Revenue Share by Application (2021-2032) Figure 66. SAMEA Hydroxychloroquine (Plaquenil) Sales Share by Application (2021-2032) Figure 67. SAMEA Hydroxychloroquine (Plaquenil) Revenue Share by Country (2021-2032) Figure 68. SAMEA Hydroxychloroquine (Plaquenil) Sales Share by Country (2021-2032) Figure 69. Hydroxychloroquine (Plaquenil) Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Hydroxychloroquine (Plaquenil) Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 200mg
  • Other
Applications
  • COVID-19
  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Others
Companies covered
  • Actavis (TEVA )
  • Advanz Pharma
  • Aphena Pharma
  • Apotex Corporation
  • AvKARE (Amneal Pharmaceuticals)
  • Bristol Laboratories
  • Cadila Healthcare
  • Cardinal Health
  • Cinkate Corporation
  • Concordia Healthcare
  • Covis Pharmaceutical
  • Hanlim Pharmaceutical
  • Hikma Pharmaceuticals
  • Ipca Laboratories
  • Kyung Poong
  • Taj Pharmaceuticals
  • Zydus Cadila
  • Mylan
  • Novartis
  • Sanofi
  • Shanghai Pharmaceuticals Holding
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hydroxychloroquine (Plaquenil) Market by Type
  3. 1.2.1 Global Hydroxychloroquine (Plaquenil) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100mg
  5. 1.2.3 200mg
  6. 1.2.4 Other
  7. 1.3 Hydroxychloroquine (Plaquenil) Market by Application
  8. 1.3.1 Global Hydroxychloroquine (Plaquenil) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 COVID-19
  10. 1.3.3 Rheumatoid Arthritis
  11. 1.3.4 Lupus Erythematosus
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Hydroxychloroquine (Plaquenil) Market Dynamics
  1. 2.1 Hydroxychloroquine (Plaquenil) Industry Trends
  2. 2.2 Hydroxychloroquine (Plaquenil) Industry Drivers
  3. 2.3 Hydroxychloroquine (Plaquenil) Industry Opportunities and Challenges
  4. 2.4 Hydroxychloroquine (Plaquenil) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hydroxychloroquine (Plaquenil) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hydroxychloroquine (Plaquenil) Revenue by Region
  3. 3.2.1 Global Hydroxychloroquine (Plaquenil) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hydroxychloroquine (Plaquenil) Revenue by Region (2021-2026)
  5. 3.2.3 Global Hydroxychloroquine (Plaquenil) Revenue by Region (2027-2032)
  6. 3.2.4 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hydroxychloroquine (Plaquenil) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hydroxychloroquine (Plaquenil) Sales by Region
  9. 3.4.1 Global Hydroxychloroquine (Plaquenil) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hydroxychloroquine (Plaquenil) Sales by Region (2021-2026)
  11. 3.4.3 Global Hydroxychloroquine (Plaquenil) Sales by Region (2027-2032)
  12. 3.4.4 Global Hydroxychloroquine (Plaquenil) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hydroxychloroquine (Plaquenil) Revenue by Manufacturers
  2. 4.1.1 Global Hydroxychloroquine (Plaquenil) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hydroxychloroquine (Plaquenil) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hydroxychloroquine (Plaquenil) Sales by Manufacturers
  6. 4.2.1 Global Hydroxychloroquine (Plaquenil) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hydroxychloroquine (Plaquenil) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hydroxychloroquine (Plaquenil) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hydroxychloroquine (Plaquenil) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hydroxychloroquine (Plaquenil) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hydroxychloroquine (Plaquenil) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hydroxychloroquine (Plaquenil) Manufacturers, Product Type & Application
  13. 4.7 Global Hydroxychloroquine (Plaquenil) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hydroxychloroquine (Plaquenil) Market CR5 and HHI
  16. 4.8.2 2025 Hydroxychloroquine (Plaquenil) Tier 1, Tier 2, and Tier 3
5 Hydroxychloroquine (Plaquenil) Market by Type
  1. 5.1 Global Hydroxychloroquine (Plaquenil) Revenue by Type
  2. 5.1.1 Global Hydroxychloroquine (Plaquenil) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hydroxychloroquine (Plaquenil) Sales by Type
  6. 5.2.1 Global Hydroxychloroquine (Plaquenil) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hydroxychloroquine (Plaquenil) Sales by Type (2021-2032) & (M Pcs)
  8. 5.2.3 Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hydroxychloroquine (Plaquenil) Price by Type
6 Hydroxychloroquine (Plaquenil) Market by Application
  1. 6.1 Global Hydroxychloroquine (Plaquenil) Revenue by Application
  2. 6.1.1 Global Hydroxychloroquine (Plaquenil) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hydroxychloroquine (Plaquenil) Sales by Application
  6. 6.2.1 Global Hydroxychloroquine (Plaquenil) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hydroxychloroquine (Plaquenil) Sales by Application (2021-2032) & (M Pcs)
  8. 6.2.3 Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hydroxychloroquine (Plaquenil) Price by Application
7 Company Profiles
  1. 7.1 Actavis (TEVA )
  2. 7.1.1 Actavis (TEVA ) Company Information
  3. 7.1.2 Actavis (TEVA ) Business Overview
  4. 7.1.3 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product Portfolio
  6. 7.1.5 Actavis (TEVA ) Recent Developments
  7. 7.2 Advanz Pharma
  8. 7.2.1 Advanz Pharma Company Information
  9. 7.2.2 Advanz Pharma Business Overview
  10. 7.2.3 Advanz Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Advanz Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
  12. 7.2.5 Advanz Pharma Recent Developments
  13. 7.3 Aphena Pharma
  14. 7.3.1 Aphena Pharma Company Information
  15. 7.3.2 Aphena Pharma Business Overview
  16. 7.3.3 Aphena Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Aphena Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
  18. 7.3.5 Aphena Pharma Recent Developments
  19. 7.4 Apotex Corporation
  20. 7.4.1 Apotex Corporation Company Information
  21. 7.4.2 Apotex Corporation Business Overview
  22. 7.4.3 Apotex Corporation Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Apotex Corporation Hydroxychloroquine (Plaquenil) Product Portfolio
  24. 7.4.5 Apotex Corporation Recent Developments
  25. 7.5 AvKARE (Amneal Pharmaceuticals)
  26. 7.5.1 AvKARE (Amneal Pharmaceuticals) Company Information
  27. 7.5.2 AvKARE (Amneal Pharmaceuticals) Business Overview
  28. 7.5.3 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product Portfolio
  30. 7.5.5 AvKARE (Amneal Pharmaceuticals) Recent Developments
  31. 7.6 Bristol Laboratories
  32. 7.6.1 Bristol Laboratories Company Information
  33. 7.6.2 Bristol Laboratories Business Overview
  34. 7.6.3 Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bristol Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio
  36. 7.6.5 Bristol Laboratories Recent Developments
  37. 7.7 Cadila Healthcare
  38. 7.7.1 Cadila Healthcare Company Information
  39. 7.7.2 Cadila Healthcare Business Overview
  40. 7.7.3 Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Cadila Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio
  42. 7.7.5 Cadila Healthcare Recent Developments
  43. 7.8 Cardinal Health
  44. 7.8.1 Cardinal Health Company Information
  45. 7.8.2 Cardinal Health Business Overview
  46. 7.8.3 Cardinal Health Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Cardinal Health Hydroxychloroquine (Plaquenil) Product Portfolio
  48. 7.8.5 Cardinal Health Recent Developments
  49. 7.9 Cinkate Corporation
  50. 7.9.1 Cinkate Corporation Company Information
  51. 7.9.2 Cinkate Corporation Business Overview
  52. 7.9.3 Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Cinkate Corporation Hydroxychloroquine (Plaquenil) Product Portfolio
  54. 7.9.5 Cinkate Corporation Recent Developments
  55. 7.10 Concordia Healthcare
  56. 7.10.1 Concordia Healthcare Company Information
  57. 7.10.2 Concordia Healthcare Business Overview
  58. 7.10.3 Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Concordia Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio
  60. 7.10.5 Concordia Healthcare Recent Developments
  61. 7.11 Covis Pharmaceutical
  62. 7.11.1 Covis Pharmaceutical Company Information
  63. 7.11.2 Covis Pharmaceutical Business Overview
  64. 7.11.3 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio
  66. 7.11.5 Covis Pharmaceutical Recent Developments
  67. 7.12 Hanlim Pharmaceutical
  68. 7.12.1 Hanlim Pharmaceutical Company Information
  69. 7.12.2 Hanlim Pharmaceutical Business Overview
  70. 7.12.3 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio
  72. 7.12.5 Hanlim Pharmaceutical Recent Developments
  73. 7.13 Hikma Pharmaceuticals
  74. 7.13.1 Hikma Pharmaceuticals Company Information
  75. 7.13.2 Hikma Pharmaceuticals Business Overview
  76. 7.13.3 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio
  78. 7.13.5 Hikma Pharmaceuticals Recent Developments
  79. 7.14 Ipca Laboratories
  80. 7.14.1 Ipca Laboratories Company Information
  81. 7.14.2 Ipca Laboratories Business Overview
  82. 7.14.3 Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Ipca Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio
  84. 7.14.5 Ipca Laboratories Recent Developments
  85. 7.15 Kyung Poong
  86. 7.15.1 Kyung Poong Company Information
  87. 7.15.2 Kyung Poong Business Overview
  88. 7.15.3 Kyung Poong Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Kyung Poong Hydroxychloroquine (Plaquenil) Product Portfolio
  90. 7.15.5 Kyung Poong Recent Developments
  91. 7.16 Taj Pharmaceuticals
  92. 7.16.1 Taj Pharmaceuticals Company Information
  93. 7.16.2 Taj Pharmaceuticals Business Overview
  94. 7.16.3 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio
  96. 7.16.5 Taj Pharmaceuticals Recent Developments
  97. 7.17 Zydus Cadila
  98. 7.17.1 Zydus Cadila Company Information
  99. 7.17.2 Zydus Cadila Business Overview
  100. 7.17.3 Zydus Cadila Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Zydus Cadila Hydroxychloroquine (Plaquenil) Product Portfolio
  102. 7.17.5 Zydus Cadila Recent Developments
  103. 7.18 Mylan
  104. 7.18.1 Mylan Company Information
  105. 7.18.2 Mylan Business Overview
  106. 7.18.3 Mylan Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Mylan Hydroxychloroquine (Plaquenil) Product Portfolio
  108. 7.18.5 Mylan Recent Developments
  109. 7.19 Novartis
  110. 7.19.1 Novartis Company Information
  111. 7.19.2 Novartis Business Overview
  112. 7.19.3 Novartis Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Novartis Hydroxychloroquine (Plaquenil) Product Portfolio
  114. 7.19.5 Novartis Recent Developments
  115. 7.20 Sanofi
  116. 7.20.1 Sanofi Company Information
  117. 7.20.2 Sanofi Business Overview
  118. 7.20.3 Sanofi Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Sanofi Hydroxychloroquine (Plaquenil) Product Portfolio
  120. 7.20.5 Sanofi Recent Developments
  121. 7.21 Shanghai Pharmaceuticals Holding
  122. 7.21.1 Shanghai Pharmaceuticals Holding Company Information
  123. 7.21.2 Shanghai Pharmaceuticals Holding Business Overview
  124. 7.21.3 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product Portfolio
  126. 7.21.5 Shanghai Pharmaceuticals Holding Recent Developments
  127. 7.22 Sun Pharma
  128. 7.22.1 Sun Pharma Company Information
  129. 7.22.2 Sun Pharma Business Overview
  130. 7.22.3 Sun Pharma Hydroxychloroquine (Plaquenil) Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Sun Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
  132. 7.22.5 Sun Pharma Recent Developments
8 North America
  1. 8.1 North America Hydroxychloroquine (Plaquenil) Market Size by Type
  2. 8.1.1 North America Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2032)
  3. 8.1.2 North America Hydroxychloroquine (Plaquenil) Sales by Type (2021-2032)
  4. 8.1.3 North America Hydroxychloroquine (Plaquenil) Price by Type (2021-2032)
  5. 8.2 North America Hydroxychloroquine (Plaquenil) Market Size by Application
  6. 8.2.1 North America Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2032)
  7. 8.2.2 North America Hydroxychloroquine (Plaquenil) Sales by Application (2021-2032)
  8. 8.2.3 North America Hydroxychloroquine (Plaquenil) Price by Application (2021-2032)
  9. 8.3 North America Hydroxychloroquine (Plaquenil) Market Size by Country
  10. 8.3.1 North America Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hydroxychloroquine (Plaquenil) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hydroxychloroquine (Plaquenil) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Hydroxychloroquine (Plaquenil) Market Size by Type
  2. 9.1.1 Europe Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hydroxychloroquine (Plaquenil) Sales by Type (2021-2032)
  4. 9.1.3 Europe Hydroxychloroquine (Plaquenil) Price by Type (2021-2032)
  5. 9.2 Europe Hydroxychloroquine (Plaquenil) Market Size by Application
  6. 9.2.1 Europe Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hydroxychloroquine (Plaquenil) Sales by Application (2021-2032)
  8. 9.2.3 Europe Hydroxychloroquine (Plaquenil) Price by Application (2021-2032)
  9. 9.3 Europe Hydroxychloroquine (Plaquenil) Market Size by Country
  10. 9.3.1 Europe Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hydroxychloroquine (Plaquenil) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hydroxychloroquine (Plaquenil) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Hydroxychloroquine (Plaquenil) Market Size by Type
  2. 10.1.1 China Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2032)
  3. 10.1.2 China Hydroxychloroquine (Plaquenil) Sales by Type (2021-2032)
  4. 10.1.3 China Hydroxychloroquine (Plaquenil) Price by Type (2021-2032)
  5. 10.2 China Hydroxychloroquine (Plaquenil) Market Size by Application
  6. 10.2.1 China Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2032)
  7. 10.2.2 China Hydroxychloroquine (Plaquenil) Sales by Application (2021-2032)
  8. 10.2.3 China Hydroxychloroquine (Plaquenil) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hydroxychloroquine (Plaquenil) Market Size by Type
  2. 11.1.1 Asia Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hydroxychloroquine (Plaquenil) Sales by Type (2021-2032)
  4. 11.1.3 Asia Hydroxychloroquine (Plaquenil) Price by Type (2021-2032)
  5. 11.2 Asia Hydroxychloroquine (Plaquenil) Market Size by Application
  6. 11.2.1 Asia Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hydroxychloroquine (Plaquenil) Sales by Application (2021-2032)
  8. 11.2.3 Asia Hydroxychloroquine (Plaquenil) Price by Application (2021-2032)
  9. 11.3 Asia Hydroxychloroquine (Plaquenil) Market Size by Country
  10. 11.3.1 Asia Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hydroxychloroquine (Plaquenil) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hydroxychloroquine (Plaquenil) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hydroxychloroquine (Plaquenil) Market Size by Type
  2. 12.1.1 SAMEA Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hydroxychloroquine (Plaquenil) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hydroxychloroquine (Plaquenil) Price by Type (2021-2032)
  5. 12.2 SAMEA Hydroxychloroquine (Plaquenil) Market Size by Application
  6. 12.2.1 SAMEA Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hydroxychloroquine (Plaquenil) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hydroxychloroquine (Plaquenil) Price by Application (2021-2032)
  9. 12.3 SAMEA Hydroxychloroquine (Plaquenil) Market Size by Country
  10. 12.3.1 SAMEA Hydroxychloroquine (Plaquenil) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hydroxychloroquine (Plaquenil) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hydroxychloroquine (Plaquenil) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hydroxychloroquine (Plaquenil) Value Chain Analysis
  2. 13.1.1 Hydroxychloroquine (Plaquenil) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hydroxychloroquine (Plaquenil) Production Mode & Process
  6. 13.2 Hydroxychloroquine (Plaquenil) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hydroxychloroquine (Plaquenil) Distributors
  9. 13.2.3 Hydroxychloroquine (Plaquenil) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst